05 March 2026
05 March 2026
Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.
By blocking the JAK and ROCK pathways, rovadicitinib offers a differentiated mechanism of action to best-selling, single-target GVHD drugs like Jakavi and Imbruvica.
The designation aims to accelerate medicines that address unmet medical needs in serious conditions.
CordenPharma Colorado will occupy the 5505 Central building under a 15-year lease.
New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.
While some chief executives have left for personal reasons, others have been ousted amid poor company performance.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
